Gianni Belcaro and A. N. Nicolaides

Natural Drugs in Vascular Medicine: New Observations
J Cardiovasc Pharmacol Ther 2002 7: S1. [PDF] [References]  

M. T. DeSanctis, M. R. Cesarone, L. Incandela, G. Belcaro, and G. Acerbi

Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy)
J Cardiovasc Pharmacol Ther 2002 7: S3-S6. [Abstract] [PDF] [References]  

L. Incandela, G. Belcaro, S. Renton, M. T. DeSanctis, M. R. Cesarone, P. Bavera, E. Ippolito, M. Bucci, M. Griffin, G. Geroulakos, M. Dugall, G. Golden, and G. Acerbi

HR (Paroven, Venoruton; 0-(ß-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial
J Cardiovasc Pharmacol Ther 2002 7: S7-S10. [Abstract] [PDF] [References]  

L. Incandela, M. R. Cesarone, M. T. DeSanctis, G. Belcaro, M. Dugall, and G. Acerbi

Treatment of Diabetic Microangiopathy and Edema with HR (Paroven, Venoruton; 0-(ß-hydroxyethyl)-rutosides): A Prospective, Placebo-Controlled, Randomized Study
J Cardiovasc Pharmacol Ther 2002 7: S11-S15. [Abstract] [PDF] [References]  

M. R. Cesarone, G. Belcaro, L. Incandela, G. Geroulakos, M. Griffin, A. Lennox, M. T. DeSanctis, and G. Acerbi

Flight Microangiopathy in Medium-to-Long Distance Flights: Prevention of Edema and Microcirculation Alterations with HR (Paroven, Venoruton; 0-(ß-hydroxyethyl)-rutosides): A Prospective, Randomized, Controlled Trial
J Cardiovasc Pharmacol Ther 2002 7: S17-S20. [Abstract] [PDF] [References]  

M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Griffin, E. Ippolito, and G. Acerbi

Treatment of Edema and Increased Capillary Filtration in Venous Hypertension with HR (Paroven, Venoruton; 0-(ß-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized, Dose-Ranging Trial
J Cardiovasc Pharmacol Ther 2002 7: S21-S24. [Abstract] [PDF] [References]  

M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Dugall, and G. Acerbi

Variations in Plasma Free Radicals in Patients with Venous Hypertension with HR (Paroven, Venoruton; 0-(ß-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized Trial
J Cardiovasc Pharmacol Ther 2002 7: S25-S28. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.